Evidence map›Paper›PMID 34091713›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2021

A bicentric retrospective analysis of clinical utility of

Ali Salavati, Mehmet Gencturk, Yasemin Koksel, Allyssa N Schik, Peter R Carroll, Felix Y Feng, Steven P Rowe, Courtney Lawhn-Heath, Thomas A Hope, Jerry W Froelich

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Differences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging VersusJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ali SalavatiThe Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, USA. asalava1@jh.edu.ORCID http://orcid.org/0000-0002-1909-6175
Mehmet GencturkDepartment of Radiology, University of Minnesota, Minneapolis, MN, USA.
Yasemin KokselDepartment of Radiology, University of Minnesota, Minneapolis, MN, USA.
Allyssa N SchikDepartment of Radiology, University of Minnesota, Minneapolis, MN, USA.
Peter R CarrollDepartment of Urology, University of California, San Francisco, San Francisco, CA, USA.
Felix Y FengDepartment of Urology, University of California, San Francisco, San Francisco, CA, USA.
Steven P RoweThe Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, USA.
Courtney Lawhn-HeathDepartment of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA.
Thomas A HopeDepartment of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA.
Jerry W FroelichDepartment of Radiology, University of Minnesota, Minneapolis, MN, USA.
University of California, San Francisco · USUniversity of Minnesota · USJohns Hopkins University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose

methodsThis retrospective study included patients from two tertiary institutions who underwent

resultsOne hundred patients were included in this study. The overall detection rate on a patient-level was 79% (79/100).

conclusion

Indexed as

Prostate-Specific AntigenProstatic NeoplasmsHumansMaleNeoplasm Recurrence, LocalPositron-Emission TomographyPositron Emission Tomography Computed TomographyRetrospective StudiesProstate-Specific Antigen18F-FluciclovineBiochemical recurrencePET/CTPET/MRIPhoenix criteriaProstate cancerPSAPSA doubling time

Identifiers

PMID34091713
OpenAlexW3171958405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.